Condition
Genetic Condition
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed2
Recruiting2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07815249Not ApplicableRecruiting
Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech
NCT07073378Not ApplicableRecruiting
BCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities
NCT06671704Not ApplicableCompleted
GC-PRO Intervention
NCT03683277Phase 2Terminated
IPD in RRMM Characterized with Genomic Abnormalities of Adverse Prognostic
NCT03708991CompletedPrimary
Effectiveness of PGT-A: IVF Versus ICSI
Showing all 5 trials